Assyro AI

Orange Book product · Generic (ANDA)

IMATINIB MESYLATE

IMATINIB MESYLATE

Generic (ANDA)ANDA 204644TE ABRX MYLAN
View IMATINIB MESYLATE familyOpen on FDA Orange Book

At a glance

Jun 21, 2017

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 21, 2017

    9 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

IMATINIB MESYLATE

Strength

EQ 100MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 204644

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of IMATINIB MESYLATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo